Department of Surgery, Rush University Medical Center, Chicago, IL.
Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
Surgery. 2022 Oct;172(4):1041-1047. doi: 10.1016/j.surg.2021.11.028. Epub 2021 Dec 25.
Previous studies have demonstrated improved outcomes for patients with rectal cancer treated at higher-volume hospitals. However, little is known whether heterogeneity in this effect exists. The objective was to test whether the effect of increased annual rectal cancer resection volume on outcomes is consistent across all hospitals treating rectal cancer.
Adult stage I to III patients who underwent surgical resection for rectal adenocarcinoma from 2004 to 2016 were identified in the National Cancer Database.
We included 120,522 patients treated at 763 hospitals in this retrospective cohort study. Higher volume was linearly and incrementally related to outcomes in unadjusted analyses. In adjusted models, for an average patient at the average hospital, the effect of increasing the annual caseload of rectal cancer resections by 20 resections per year was associated with 8%, (hazard ratio = 0.92, 95% confidence interval = 0.87, 0.97), 18% (odds ratio = 0.82, 95% confidence interval = 0.70, 0.98), and 16% (odds ratio = 0.84, 95% confidence interval = 0.73, 0.95) relative reductions in 5-year overall survival, 30-, and 90-day mortality, respectively, and with a 19% (odds ratio = 1.19, 95% confidence interval = 1.04, 1.36) relative increase in the rate of neoadjuvant chemoradiation. These effects varied by individual hospitals such that 39% of hospitals do not see any benefit in 5-year overall survival associated with higher volumes. Increased volume was associated with lower positive circumferential resection margin rates at 19% of the hospitals.
This study confirms that higher-volume hospitals have improved outcomes after rectal cancer surgery. However, there exists significant variation in these effects induced by individual within-hospital effects. Regionalization policies may need to be flexible in identifying the hospitals that would achieve enhanced benefits from treating a larger volume of patients.
先前的研究表明,在高容量医院接受治疗的直肠癌患者的预后有所改善。然而,对于这种效果是否存在异质性知之甚少。本研究旨在检验在所有治疗直肠癌的医院中,增加年度直肠癌切除术量对结局的影响是否一致。
本回顾性队列研究纳入了 2004 年至 2016 年期间在国家癌症数据库中接受手术切除直肠腺癌的 I 至 III 期成年患者。
本研究共纳入了 763 家医院的 120522 例患者。在未校正分析中,高容量与结果呈线性和递增关系。在调整后的模型中,对于平均医院的平均患者,每年增加 20 例直肠癌切除术的年度病例量与 5 年总生存率降低 8%(风险比=0.92,95%置信区间=0.87,0.97)、30 天死亡率降低 18%(比值比=0.82,95%置信区间=0.70,0.98)和 90 天死亡率降低 16%(比值比=0.84,95%置信区间=0.73,0.95)相关,新辅助放化疗率相对增加 19%(比值比=1.19,95%置信区间=1.04,1.36)。这些效果因个别医院而异,因此 39%的医院在 5 年总生存率方面没有看到与更高容量相关的任何益处。高容量与 19%的医院的阳性环周切缘率降低有关。
本研究证实,高容量医院的直肠癌手术后预后有所改善。然而,这些效果存在个体医院内的显著差异。区域化政策可能需要灵活地确定从治疗更多患者中获得更大效益的医院。